{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:19:06Z","timestamp":1793139546907,"version":"4.5.0"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Medication-overuse headache (MOH) develops when drugs intended for acute pain relief lower the threshold for headache chronification. The biological mechanisms driving this transition remain poorly understood. We aim to synthesize current evidence on immune and epigenetic alterations in MOH, identifying new targets of interest and outlining priorities for future research and precision-based interventions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We systematically searched PubMed, Embase and Scopus from inception to May 2025 for original human or animal studies reporting immune and\/or epigenetic measures in MOH. Risk of bias (RoB) was assessed with the SYRCLE tool for animal studies and JBI tools for human studies. Findings were narratively synthesized, and a domain-based strength-of-evidence (SoE) framework was applied.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Thirteen studies met inclusion criteria. Animal studies identified two immunological pathways involved in MOH resolution: low-dose interleukin-2-mediated expansion of regulatory T cells and inhibition of the P2X purinoceptor 7 (P2X7R)\/NLRP3 inflammasome signaling. Clinical studies reported systemic low-grade inflammation in MOH patients, including elevated leukocyte counts, interleukin-6 and gut-derived inflammatory markers. Two epigenetic studies identified differential DNA methylation in genes regulating immune responses and pain transmission. Most studies were small and cross-sectional with limited adjustment. Overall SoE was low-moderate across domains.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Current evidence points to plausible immune and epigenetic involvement in MOH but is insufficient for causal inference or clinical guidance. Findings are hypothesis-generating and most useful for translational prioritization.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1756442","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T09:13:24Z","timestamp":1768986804000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Mapping the immune and epigenetic landscape of medication-overuse headache (MOH): a systematic review"],"prefix":"10.3389","volume":"17","author":[{"given":"Nanna Elman","family":"Andersen","sequence":"first","affiliation":[{"name":"Research Unit, Hospital Pharmacy Funen, Odense University Hospital","place":["Odense, Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Waliszewska-Pros\u00f3\u0142","sequence":"additional","affiliation":[{"name":"Department of Neurology, Wroclaw Medical University","place":["Wroclaw, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanfranco","family":"Pellesi","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark","place":["Odense, Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-022-00415-0","article-title":"Medication overuse headache","volume":"9","author":"Ashina","year":"2023","journal-title":"Nat Rev Dis Prim"},{"key":"B2","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.pain.2011.08.018","article-title":"Risk factors for medication-overuse headache: an 11-year follow-up study","volume":"153","author":"Hagen","year":"2012","journal-title":"Nord-Tr\u00f8ndel Health Stud Pain"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/s-0045-1809658","article-title":"Calcitonin gene-related peptide monoclonal antibodies and medication overuse headache: is stopping excessive pain medication still necessary","volume":"83","author":"Carvalho","year":"2025","journal-title":"Arq Neuropsiquiatr"},{"key":"B4","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1177\/0333102412467512","article-title":"Medication-overuse headache and opioid-induced hyperalgesia: A review of mechanisms, a neuroimmune hypothesis and a novel approach to treatment","volume":"33","author":"Johnson","year":"2013","journal-title":"Cephalalgia"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.nrleng.2017.10.006","article-title":"Epigenetic changes in headache","volume":"36","author":"C\u00e1mara","year":"2021","journal-title":"Neurologia (Engl Ed)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/head.12655","article-title":"Glial Attenuation With Ibudilast in the Treatment of Medication Overuse Headache: A Double-Blind, Randomized, Placebo-Controlled Pilot Trial of Efficacy and Safety","volume":"55","author":"Johnson","year":"2015","journal-title":"Headache"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-43","article-title":"SYRCLE\u2019s risk of bias tool for animal studies","volume":"14","author":"Hooijmans","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.11124\/JBIES-23-00268","article-title":"The revised JBI critical appraisal tool for the assessment of risk of bias quasi-experimental studies","volume":"22","author":"Barker","year":"2024","journal-title":"JBI Evid Synth"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.11124\/JBIES-24-00523","article-title":"The revised JBI critical appraisal tool for the assessment of risk of bias for analytical cross-sectional studies","author":"Barker","year":"2025","journal-title":"JBI Evid Synth"},{"key":"B11","doi-asserted-by":"publisher","first-page":"494","DOI":"10.11124\/JBIES-22-00430","article-title":"The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials","volume":"21","author":"Barker","year":"2023","journal-title":"JBI Evid Synth"},{"key":"B12","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s10194-024-01900-5","article-title":"Regulatory T cells require peripheral CCL2-CCR2 signaling to facilitate the resolution of medication overuse headache-related behavioral sensitization","volume":"25","author":"Ryu","year":"2024","journal-title":"J Headache Pain"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000001818","article-title":"Low-dose interleukin-2 reverses behavioral sensitization in multiple mouse models of headache disorders","volume":"161","author":"Zhang","year":"2020","journal-title":"Pain"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2023.1177171","article-title":"Activation of the microglial P2X7R\/NLRP3 inflammasome mediates central sensitization in a mouse model of medication overuse headache","volume":"16","author":"Wang","year":"2023","journal-title":"Front Mol Neurosci"},{"key":"B15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.55730\/1300-0144.5763","article-title":"Leaky gut and inflammatory biomarkers in a medication overuse headache model in male rats","volume":"54","author":"Vuralli","year":"2023","journal-title":"Turk J Med Sci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s10194-023-01672-4","article-title":"Medication overuse headache is associated with elevated lipopolysaccharide binding protein and pro-inflammatory molecules in the bloodstream","volume":"24","author":"Da\u011f\u0131d\u0131r","year":"2023","journal-title":"J Headache Pain"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3988\/jcn.2012.8.4.301","article-title":"Association between the G252A Tumor Necrosis Factor-\u03b2 Gene Polymorphism and Medication-Overuse Headache","volume":"8","author":"Ishii","year":"2012","journal-title":"J Clin Neurol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2011.01902.x","article-title":"Analysis of leukocytes in medication-overuse headache, chronic migraine, and episodic migraine","volume":"51","author":"Forcelini","year":"2011","journal-title":"Headache"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-014-1763-z","article-title":"Evaluation of immune parameters in chronic migraine with medication overuse","volume":"35","author":"Grazzi","year":"2014","journal-title":"Neurol Sci"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1177\/03331024221147482","article-title":"DNA-methylation and immunological response in medication overuse headache","volume":"43","author":"Carlsen","year":"2023","journal-title":"Cephalalgia"},{"key":"B21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s10194-024-01730-5","article-title":"Lipopolysaccharide, VE-cadherin, HMGB1, and HIF-1\u03b1 levels are elevated in the systemic circulation in chronic migraine patients with medication overuse headache: evidence of leaky gut and inflammation","volume":"25","author":"Vuralli","year":"2024","journal-title":"J Headache Pain"},{"key":"B22","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s10194-024-01891-3","article-title":"Microbiota alterations are related to migraine food triggers and inflammatory markers in chronic migraine patients with medication overuse headache","volume":"25","author":"Vuralli","year":"2024","journal-title":"J Headache Pain"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/ane.12692","article-title":"Greater occipital nerve block in the treatment of triptan-overuse headache: A randomized comparative study","volume":"135","author":"Karada\u015f","year":"2017","journal-title":"Acta Neurol Scand"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2022.05.007","article-title":"Histone Deacetylase Inhibitors Counteract CGRP Signaling and Pronociceptive Sensitization in a Rat Model of Medication Overuse Headache","volume":"23","author":"Urru","year":"2022","journal-title":"J Pain"},{"key":"B25","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40246-015-0051-1","article-title":"HDAC3 role in medication consumption in medication overuse headache patients: a pilot study","volume":"9","author":"Pisanu","year":"2015","journal-title":"Hum Genomics"},{"key":"B26","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s13148-023-01604-8","article-title":"Alterations in DNA methylation associate with reduced migraine and headache days after medication withdrawal treatment in chronic migraine patients: a longitudinal study","volume":"15","author":"Mehta","year":"2023","journal-title":"Clin Epigenet"},{"key":"B27","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12974-016-0607-6","article-title":"Interleukin-6: an emerging regulator of pathological pain","volume":"13","author":"Zhou","year":"2016","journal-title":"J Neuroinflamm"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104402","article-title":"Il-6 Involvement in pain, fatigue and mood disorders in rheumatoid arthritis and the effects of Il-6 inhibitor sarilumab","volume":"149","author":"Atzeni","year":"2019","journal-title":"Pharmacol Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1177\/03331024221118924","article-title":"The role of cytokines in migraine: A systematic review","volume":"42","author":"Thuraiaiyah","year":"2022","journal-title":"Cephalalgia"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.999407","article-title":"Interleukin-17 as a potential therapeutic target for chronic pain","volume":"13","author":"Jiang","year":"2022","journal-title":"Front Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2010.08.003","article-title":"Interleukin-17 contributes to neuroinflammation and neuropathic pain following peripheral nerve injury in mice","volume":"12","author":"Kim","year":"2011","journal-title":"J Pain"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-021-01374-9","article-title":"IL-17 crosses the blood-brain barrier to trigger neuroinflammation: a novel mechanism in nitroglycerin-induced chronic migraine","volume":"23","author":"Chen","year":"2022","journal-title":"J Headache Pain"},{"key":"B33","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41584-018-0051-3","article-title":"Pain relief with secukinumab treatment","volume":"14","author":"Leake","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awad303","article-title":"Microbiota from Alzheimer\u2019s patients induce deficits in cognition and hippocampal neurogenesis","volume":"146","author":"Grabrucker","year":"2023","journal-title":"Brain"},{"key":"B35","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s40035-023-00392-8","article-title":"Parkinson\u2019s disease and gut microbiota: from clinical to mechanistic and therapeutic studies","volume":"12","author":"Zhang","year":"2023","journal-title":"Transl Neurodegener"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/s0306-4522(02)00078-7","article-title":"Interleukin-2 gene therapy of chronic neuropathic pain","volume":"112","author":"Yao","year":"2002","journal-title":"Neuroscience"},{"key":"B37","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41392-022-00887-2","article-title":"Efficacy and safety of low-dose interleukin-2 in combination with methotrexate in patients with active rheumatoid arthritis: a randomized, double-blind, placebo-controlled phase 2 trial","volume":"7","author":"Zhang","year":"2022","journal-title":"Signal Transduct Targ Ther"},{"key":"B38","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.immuni.2024.01.018","article-title":"Disruption of the Na+\/K+-ATPase-purinergic P2X7 receptor complex in microglia promotes stress-induced anxiety","volume":"57","author":"Huang","year":"2024","journal-title":"Immunity"},{"key":"B39","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s10194-021-01271-1","article-title":"Migraine and neuroinflammation: the inflammasome perspective","volume":"22","author":"Kursun","year":"2021","journal-title":"J Headache Pain"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-020-02056-0","article-title":"P2X7R-mediated autophagic impairment contributes to central sensitization in a chronic migraine model with recurrent nitroglycerin stimulation in mice","volume":"18","author":"Jiang","year":"2021","journal-title":"J Neuroinflamm"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1186\/1129-2377-15-24","article-title":"Effect of genetic deletion and pharmacological antagonism of P2X7 receptors in a mouse animal model of migraine","volume":"15","author":"G\u00f6l\u00f6ncs\u00e9r","year":"2014","journal-title":"J Headache Pain"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10555","article-title":"Neutrophil P2X7 receptors mediate NLRP3 inflammasome-dependent IL-1\u03b2 secretion in response to ATP","volume":"7","author":"Karmakar","year":"2016","journal-title":"Nat Commun"},{"key":"B43","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12974-019-1459-7","article-title":"Microglial NLRP3 inflammasome activation mediates IL-1\u03b2 release and contributes to central sensitization in a recurrent nitroglycerin-induced migraine model","volume":"16","author":"He","year":"2019","journal-title":"J Neuroinflamm"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1042\/BST20190760","article-title":"Function and regulation of corin in physiology and disease","volume":"48","author":"Dong","year":"2020","journal-title":"Biochem Soc Trans"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1080\/21688370.2021.1926190","article-title":"The blood-brain and gut-vascular barriers: from the perspective of claudins","volume":"9","author":"Scalise","year":"2021","journal-title":"Tissue Barriers"},{"key":"B46","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s42003-021-02992-4","article-title":"The metabolic stress-activated checkpoint LKB1-MARK3 axis acts as a tumor suppressor in high-grade serous ovarian carcinoma","volume":"5","author":"Machino","year":"2022","journal-title":"Commun Biol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3390\/ph14111185","article-title":"The Cholecystokinin Type 2 Receptor, a Pharmacological Target for Pain Management","volume":"14","author":"Bernard","year":"2021","journal-title":"Pharm (Basel)"},{"key":"B48","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/s41467-022-28357-x","article-title":"Organic anion transporter 1 is an HDAC4-regulated mediator of nociceptive hypersensitivity in mice","volume":"13","author":"Litke","year":"2022","journal-title":"Nat Commun"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1080\/15592294.2019.1640546","article-title":"Epidrugs: targeting epigenetic marks in cancer treatment","volume":"14","author":"Miranda Furtado","year":"2019","journal-title":"Epigenetics"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M101287200","article-title":"Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen","volume":"276","author":"Phiel","year":"2001","journal-title":"J Biol Chem"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.2174\/1874467213666200512080122","article-title":"Azacitidine, as a DNMT Inhibitor Decreases hTERT Gene Expression and Telomerase Activity More Effective Compared with HDAC Inhibitor in Human Head and Neck Squamous Cell Carcinoma Cell Lines","volume":"14","author":"Atri","year":"2021","journal-title":"Curr Mol Pharmacol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1021\/acsptsci.3c00219","article-title":"Apabetalone (RVX-208): A Potential Epigenetic Therapy for the Treatment of Cardiovascular, Renal, Neurological, Viral, and Cancer Disorders","volume":"7","author":"Dhulkifle","year":"2024","journal-title":"ACS Pharmacol Transl Sci"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3087916","article-title":"HDAC4 Inhibitors as Antivascular Senescence Therapeutics","volume":"2022","author":"Huang","year":"2022","journal-title":"Oxid Med Cell Longev"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1756442\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T09:13:25Z","timestamp":1768986805000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1756442\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":53,"alternative-id":["10.3389\/fimmu.2026.1756442"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1756442","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"article-number":"1756442"}}